BRIEF-Pain Therapeutics Q3 loss per share $0.08
October 20, 2016 at 09:18 AM EDT
* Pain Therapeutics Inc- "we continue to evaluate comments recently raised by FDA with regards to remoxy"
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.